NO944846L - Fremgangsmåte for fremstilling av protein C - Google Patents

Fremgangsmåte for fremstilling av protein C

Info

Publication number
NO944846L
NO944846L NO944846A NO944846A NO944846L NO 944846 L NO944846 L NO 944846L NO 944846 A NO944846 A NO 944846A NO 944846 A NO944846 A NO 944846A NO 944846 L NO944846 L NO 944846L
Authority
NO
Norway
Prior art keywords
protein
cell lines
degrees centigrade
recombinant proteins
higher levels
Prior art date
Application number
NO944846A
Other languages
English (en)
Norwegian (no)
Other versions
NO944846D0 (no
Inventor
Brian William Grinnell
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO944846D0 publication Critical patent/NO944846D0/no
Publication of NO944846L publication Critical patent/NO944846L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO944846A 1993-12-15 1994-12-14 Fremgangsmåte for fremstilling av protein C NO944846L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/168,035 US5618714A (en) 1993-12-15 1993-12-15 Methods for producing protein C

Publications (2)

Publication Number Publication Date
NO944846D0 NO944846D0 (no) 1994-12-14
NO944846L true NO944846L (no) 1995-06-16

Family

ID=22609820

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944846A NO944846L (no) 1993-12-15 1994-12-14 Fremgangsmåte for fremstilling av protein C

Country Status (28)

Country Link
US (1) US5618714A (fr)
EP (1) EP0658626B1 (fr)
JP (1) JP3662614B2 (fr)
KR (1) KR950018454A (fr)
CN (1) CN1107887A (fr)
AT (1) ATE196165T1 (fr)
AU (1) AU687914B2 (fr)
BR (1) BR9404991A (fr)
CA (1) CA2138101A1 (fr)
CO (1) CO4340654A1 (fr)
CZ (2) CZ315794A3 (fr)
DE (1) DE69425809T2 (fr)
DK (1) DK0658626T3 (fr)
ES (1) ES2149244T3 (fr)
FI (1) FI106385B (fr)
GR (1) GR3034909T3 (fr)
HU (1) HU219508B (fr)
IL (1) IL111983A0 (fr)
NO (1) NO944846L (fr)
NZ (1) NZ270140A (fr)
PE (1) PE42695A1 (fr)
PL (1) PL176381B1 (fr)
PT (1) PT658626E (fr)
RU (1) RU2110574C1 (fr)
SI (1) SI0658626T1 (fr)
UA (1) UA26870C2 (fr)
YU (1) YU73494A (fr)
ZA (1) ZA949981B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19724543A1 (de) * 1997-06-11 1998-12-17 Philips Patentverwaltung Wechsler-Gerät für Informationsplatten
WO2002069232A2 (fr) 2001-02-19 2002-09-06 Merck Patent Gmbh Procede d'identification d'epitopes de lymphocytes t et utilisation dans la preparation de molecules a immunogenicite reduite
WO2003085138A1 (fr) * 2002-03-29 2003-10-16 Merck & Co., Inc. Procedes de production de virus
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
CA2574598A1 (fr) * 2004-07-23 2006-02-09 The University Of Rochester La proteine c activee inhibe les effets secondaires de l'activateur de plasminogene dans le cerveau
WO2006136033A1 (fr) * 2005-06-23 2006-12-28 The University Of British Columbia Polymorphismes de facteur de coagulation iii associes a une prediction relative aux resultats et a la reponse d'un sujet a une therapie
CA2654761A1 (fr) * 2006-06-09 2007-12-13 The University Of British Columbia Polymorphismes de l'interferon gamma utilises comme indicateurs de resultat chez des sujets gravement malades
CA2712057A1 (fr) * 2008-01-15 2009-07-23 The University Of British Columbia Proteine c rs2069915 en tant que predicteur de reponse de survie et administration de proteine c ou d'un compose de type proteine c active
WO2012068519A2 (fr) 2010-11-19 2012-05-24 Sirius Genomics Inc. Marqueurs associés à la réponse à une administration de la protéine c activée, et leurs utilisations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
US4968626A (en) * 1985-08-15 1990-11-06 Board Of Reagents Of The University Of Washington DNA sequence coding for protein C
EP0245949B1 (fr) * 1986-04-09 1997-10-29 Eli Lilly And Company Méthode d'utilisation des vecteurs d'expression eucaryotiques comportant les séquences stimulantes du virus BK
WO1988003926A1 (fr) * 1986-11-17 1988-06-02 New England Medical Center Amelioration de la gamma-carboxylation de proteines recombinantes dependantes de la vitamine k
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
ZA889497B (en) * 1987-12-28 1990-08-29 Lilly Co Eli Vectors and compounds for expression of zymogen forms of human protein c
JPH0246296A (ja) * 1988-08-09 1990-02-15 Hoechst Japan Ltd 雑種プロテインｃ及びその製造方法
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
CA1332049C (fr) * 1988-10-07 1994-09-20 Eli Lilly And Company Expression eucaryotique
EP0485504B1 (fr) * 1989-08-11 1993-12-01 Zymogenetics, Inc. Procedes de culture de cellules pour la production de proteine c activee
IL97312A (en) * 1990-02-23 1999-01-26 Lilly Co Eli A method of generating a polypeptide in an eukaryotic vector AND recombinant surrogate cell containing an enhanced transcriptional control unit based on the primary late adenovirus coefficient
AU1180692A (en) * 1991-01-29 1992-08-27 Teijin Limited Human protein c expression vector

Also Published As

Publication number Publication date
IL111983A0 (en) 1995-03-15
EP0658626B1 (fr) 2000-09-06
KR950018454A (ko) 1995-07-22
ATE196165T1 (de) 2000-09-15
JP3662614B2 (ja) 2005-06-22
GR3034909T3 (en) 2001-02-28
YU73494A (sh) 1997-03-07
HU219508B (hu) 2001-04-28
FI945877A (fi) 1995-06-16
HUT69979A (en) 1995-09-28
CA2138101A1 (fr) 1995-06-16
UA26870C2 (uk) 1999-12-29
PL306291A1 (en) 1995-06-26
ZA949981B (en) 1996-06-14
PE42695A1 (es) 1995-12-12
NZ270140A (en) 1996-05-28
NO944846D0 (no) 1994-12-14
FI945877A0 (fi) 1994-12-14
SI0658626T1 (en) 2001-02-28
CO4340654A1 (es) 1996-07-30
US5618714A (en) 1997-04-08
PT658626E (pt) 2001-01-31
DE69425809T2 (de) 2001-02-01
JPH07222589A (ja) 1995-08-22
HU9403600D0 (en) 1995-02-28
AU687914B2 (en) 1998-03-05
FI106385B (fi) 2001-01-31
DE69425809D1 (de) 2000-10-12
CZ290724B6 (cs) 2002-10-16
EP0658626A1 (fr) 1995-06-21
PL176381B1 (pl) 1999-05-31
RU94043769A (ru) 1997-03-27
DK0658626T3 (da) 2000-10-16
CN1107887A (zh) 1995-09-06
BR9404991A (pt) 1995-08-08
ES2149244T3 (es) 2000-11-01
RU2110574C1 (ru) 1998-05-10
CZ315794A3 (en) 1995-10-18
AU8045294A (en) 1995-06-22

Similar Documents

Publication Publication Date Title
NO975674D0 (no) Fremgangsmåte for å regulere sialyleringen av proteiner fremstilt av pattedyrceller i kultur
DE69112207D1 (en) "walk-through"-mutagenese.
DE68928043D1 (de) Interleukin-4-Rezeptoren
EP0318296A3 (fr) Récepteurs d'interleukine-1
FI871908A (fi) Transformering av trichoderma-moegel.
ATE109829T1 (de) Interleukin-7.
NO944846L (no) Fremgangsmåte for fremstilling av protein C
ATE330003T1 (de) Rekombinanter stabiler zellklon, seine herstellung und verwendung
NO871573L (no) Fremgangsmaate for fremstilling av peptider.
ATE97958T1 (de) Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
CA2058785A1 (fr) Methode pour l'obtention de proteines avec des derives fviii et ou a activite fviii

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application